Experimental Hematology and Oncology : Impact Factor & More
eISSN: 2162-3619pISSN: 2162-3619
Open AccessShare this on:
Key Metrics
CiteScore 
8.1
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Oncology
SNIP
1.39
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Experimental Hematology and Oncology
Experimental Hematology and Oncology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2590 | USD 2990 | GBP 2290 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in Experimental Hematology and Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Experimental Hematology and Oncology
Combining circulating tumor cell and circulating cell-free DNA analyses broadens clinical applicability of liquid biopsy in high grade serous tubo-ovarian carcinoma.
- 21 Apr 2026
- Experimental hematology & oncology
Metabolic drivers of genome instability in cancer: mechanisms and therapeutic opportunities.
- 18 Apr 2026
- Experimental hematology & oncology
Decoding the spatiotemporal characteristics of ferroptosis: reshaping tumour therapeutic strategies.
- 8 Apr 2026
- Experimental hematology & oncology
Correction: Novel non-viral in vivo CAR-T therapies: latest updates from the 2025 ASH annual meeting
- 6 Apr 2026
- Experimental Hematology & Oncology
Multi-omics analysis of patient-derived organoids reveals that E3 ligase COP1 promotes liver metastasis and oxaliplatin resistance in colorectal cancer through LUZP1 degradation and MYL9 phosphorylation.
- 5 Apr 2026
- Experimental hematology & oncology
Clinical and translational advances in regulatory T cell-based strategies in allogeneic hematopoietic stem cell transplantation: highlights from ASH 2025
- 2 Apr 2026
- Experimental Hematology & Oncology
Combining circulating tumor cell and circulating cell-free DNA analyses broadens clinical applicability of liquid biopsy in high grade serous tubo-ovarian carcinoma.
- 21 Apr 2026
- Experimental hematology & oncology
Metabolic drivers of genome instability in cancer: mechanisms and therapeutic opportunities.
- 18 Apr 2026
- Experimental hematology & oncology
Decoding the spatiotemporal characteristics of ferroptosis: reshaping tumour therapeutic strategies.
- 8 Apr 2026
- Experimental hematology & oncology
Correction: Novel non-viral in vivo CAR-T therapies: latest updates from the 2025 ASH annual meeting
- 6 Apr 2026
- Experimental Hematology & Oncology
Multi-omics analysis of patient-derived organoids reveals that E3 ligase COP1 promotes liver metastasis and oxaliplatin resistance in colorectal cancer through LUZP1 degradation and MYL9 phosphorylation.
- 5 Apr 2026
- Experimental hematology & oncology
Clinical and translational advances in regulatory T cell-based strategies in allogeneic hematopoietic stem cell transplantation: highlights from ASH 2025
- 2 Apr 2026
- Experimental Hematology & Oncology
FAQs on Experimental Hematology and Oncology
How long has Experimental Hematology and Oncology been actively publishing? 
What is the publishing frequency of Experimental Hematology and Oncology?
How many articles did Experimental Hematology and Oncology publish last year?
What is the eISSN & pISSN for Experimental Hematology and Oncology?
What is Citescore for Experimental Hematology and Oncology?
What is SNIP score for Experimental Hematology and Oncology?
What is the SJR for Experimental Hematology and Oncology?
Who is the publisher of Experimental Hematology and Oncology?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations